Recombinant GBA Monoclonal Antibody
Produktgrößen
50 ul
£281,00
AN301962L-50UL
100 ul
£402,00
AN301962L-100UL
Über dieses Produkt
- SKU:
- AN301962L
- Zusätzliche Namen:
- GBA,GBA1,GCB,GLUC,GC,9-O-sialyl GD3,7-O-sialyl GD3,ACID,acid (includes glucosylceramidase),beta,Acid beta glucosidase,Acid beta-glucosidase,Alglucerase,Beta glucocerebrosidase,BETA GLUCOSIDASE,betaGC,Beta-glucocerebrosidase,D glucosyl N acylsphingosine glucohydrolase,D-glucosyl-N-acylsphingosine glucohydrolase,EC 3.2.1.45,Gba protein,GCase,GLCM,Glucocerebrosidase,Glucocerebrosidase (alt.),GLUCOCEREBROSIDASE PSEUDOGENE,Glucosidase,Glucosidase beta,Glucosylceramidase,Imiglucerase,Lysosomal glucocerebrosidase,OTTHUMP00000033992,OTTHUMP00000033993
- Anwendung:
- Immunohistochemistry, Western Blot
- Buffer:
- PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
- translate.label.attr.clone:
- A678
- Klonalität:
- Recombinant Monoclonal
- Konzentration:
- 1 mg/ml
- Weitere Details:
- Beta-Glucosylceramidase (B Beta-GC) is a lysosomal enzyme that catalyzes the hydrolysis of glucocerebroside into free ceramide and glucose. Lysosomal breakdown of glucocerebroside is required for cellular metabolism of complex lipids and proper turnover of cellular membrane. In the absence of GBA, the gene that encodes B Beta-GC, autophagic lysosome reformation is altered, suggesting that B Beta-GC activity is critical to maintain functional lysosomes. The cellular function of lysosomes is to degrade and recycle cellular waste to maintain proper cellular energy metabolism. Mutations in human GBA cause deficiency in B Beta-GC, resulting in the accumulation of lysosomal glucocerebroside. Macrophages are particularly sensitive to lysosomal glucocerebroside accumulation due to their role in phagocytosis-mediated breakdown of cellular debris and dying cells. Gaucher disease, a rare autosomal recessive lysosomal storage disorder that is genetically linked to GBA, is marked by engorged "Gaucher cell" macrophages in the spleen, liver, and bone marrow. GBA mutations are the most common genetic risk factor for Parkinson's disease (PD), a neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra with formation of A Alpha-synuclein-rich Lewy bodies in surviving neurons. GBA mutations may play a direct role in accumulation of A Alpha-synuclein by mechanisms that are poorly understood, but may include mislocalization of lysosomal B Beta-GC causing impaired lysosomal degradation of A Alpha-synuclein.
- Host:
- Rabbit
- Immunogen:
- Recombinant human GBA fragment
- Isotyp:
- IgG, kappa
- Aufreinigung:
- Protein A Purified
- Reaktivitäten:
- Human, Mouse, Rat
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- -20[o]C Avoid freeze/thaw cycles.
- Hersteller:
- Elabscience
- Typ:
- Antibody: Recombinant Antibodies
- Datenblatt des Herstellers:p-recombinant_gba_monoclonal_antibody-an301962l